These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 15083963

  • 1. [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].
    Noroña B, Valentín M, Gutiérrez E, Praga M.
    Nefrologia; 2004; 24(1):79-82. PubMed ID: 15083963
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
    Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H.
    Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A, Lippman HR, Feldman GM.
    Am J Nephrol; 2002 Sep; 22(5-6):569-72. PubMed ID: 12381961
    [Abstract] [Full Text] [Related]

  • 4. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T, Nast CC, Vo A, Jordan SC.
    Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in minimal change nephrosis.
    Alfred R, Soyibo AK.
    West Indian Med J; 2010 Jun; 59(3):330-1. PubMed ID: 21291117
    [No Abstract] [Full Text] [Related]

  • 6. The use of enteric-coated mycophenolate sodium in the treatment of relapsing and steroid-dependent minimal change disease.
    Siu YP, Tong MK, Leung Ka, Kwan TH, Au TC.
    J Nephrol; 2008 Jun; 21(1):127-31. PubMed ID: 18264946
    [Abstract] [Full Text] [Related]

  • 7. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy.
    Pesavento TE, Bay WH, Agarwal G, Hernandez RA, Hebert LA.
    Am J Kidney Dis; 2004 Mar 23; 43(3):e3-6. PubMed ID: 14981634
    [Abstract] [Full Text] [Related]

  • 9. [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].
    Cailliez M, Bruno D, Daniel L, Afaneti M, Bérard E, Sarles J, Tsimaratos M.
    Nephrol Ther; 2008 Feb 23; 4(1):15-20. PubMed ID: 18096455
    [Abstract] [Full Text] [Related]

  • 10. Using mycophenolate mofetil in steroid-resistant nephrotic syndrome.
    Ganji MR.
    Iran J Kidney Dis; 2012 Sep 23; 6(5):323-5. PubMed ID: 22976252
    [No Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.
    Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D.
    Nephrol Dial Transplant; 2002 Nov 23; 17(11):2011-3. PubMed ID: 12401863
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A.
    Kidney Int; 2008 Jan 23; 73(2):154-62. PubMed ID: 17989649
    [Abstract] [Full Text] [Related]

  • 13. Successful mycophenolate mofetil treatment of glomerular disease.
    Briggs WA, Choi MJ, Scheel PJ.
    Am J Kidney Dis; 1998 Feb 23; 31(2):213-7. PubMed ID: 9469489
    [Abstract] [Full Text] [Related]

  • 14. [Mycophenolate mofetil and cyclosporine in the treatment of steroid-dependent nephrotic syndrome with frequent relapses].
    Márquez Peiró JF, Porta Oltra B, Marín Serra J.
    An Pediatr (Barc); 2008 Sep 23; 69(3):258-62. PubMed ID: 18775272
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F, Liebl R, Riegger GA, Krämer BK.
    Nephrol Dial Transplant; 1997 Nov 23; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract] [Full Text] [Related]

  • 16. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
    Chandra M, Susin M, Abitbol C.
    Pediatr Nephrol; 2000 Mar 23; 14(3):224-6. PubMed ID: 10752763
    [Abstract] [Full Text] [Related]

  • 17. Late de novo minimal change disease in a renal allograft.
    Madhan KK, Temple-Camp CR.
    Saudi J Kidney Dis Transpl; 2009 Mar 23; 20(2):266-9. PubMed ID: 19237816
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
    Nickavar A, Safarzadeh AE, Sotoudeh K, Otukesh H, Hooman N.
    Iran J Kidney Dis; 2012 Sep 23; 6(5):346-9. PubMed ID: 22976259
    [Abstract] [Full Text] [Related]

  • 19. The treatment of minimal change disease in adults.
    Hogan J, Radhakrishnan J.
    J Am Soc Nephrol; 2013 Apr 23; 24(5):702-11. PubMed ID: 23431071
    [Abstract] [Full Text] [Related]

  • 20. The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts.
    Shigidi MM.
    Saudi J Kidney Dis Transpl; 2011 Jan 23; 22(1):10-7. PubMed ID: 21196608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.